Violence in ICU: Outcomes, Lessons, and Experiences of ICU Team (The VIOLENT-Study)
NCT ID: NCT06921083
Last Updated: 2025-04-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
500 participants
OBSERVATIONAL
2025-03-01
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Usage and Adverse Events of Physical Restraints in an Intensive Care Unit
NCT06921070
Adverse Events in the Tracheal Intubation in the Intensive Care Unit
NCT03916224
Apneic Intubation Critically Ill Children
NCT04890288
Non Invasive Ventilation (NIV) Related Practices, Monitoring of the NIV Treatment Effect and of the Patient's Comfort
NCT01692509
Health-related Quality of Life and Nursing-sensitive Outcomes in Mechanically Ventilated Patients
NCT02636660
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study examines the perceptions, experiences, and responses of healthcare professionals in Swiss ICUs. A questionnaire-based survey will assess various aspects, including personal background (such as education and professional role), the frequency and nature of past incidents of workplace violence, responses and measures taken, psychological or professional consequences, current prevention strategies, and suggestions for improving workplace safety.
Since workplace violence is a common issue, the results of this study could help improve the work environment and safety in ICUs and other healthcare settings.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Nurses and physicians consenting to participate will be included
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Basel, Switzerland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Raoul Sutter, Prof. Dr. med.
Role: PRINCIPAL_INVESTIGATOR
University Hospital Basel, Department of Acute Medicine, Intensive Care Unit
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Basel, Intensive Care Unit
Basel, Canton of Basel-City, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Req-2024-01621; am25Sutter2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.